UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Reply to: Optimising the treatment of HDV infection: efficacy of Bulevirtide, HBV-HDV interactions and the importance of statistical methods

Journal of hepatology, 2024-10

2024

Volltextzugriff (PDF)

POS0536 FILGOTINIB DEMONSTRATES CLINICAL EFFICACY IN RHEUMATOID ARTHRITIS INDEPENDENT OF SMOKING STATUS: A POST-HOC SUBGROUP ANALYSIS OF THREE PHASE 3 CLINICAL TRIALS

Annals of the rheumatic diseases, 2021-06, Vol.80 (Suppl 1), p.502-502

2021

Volltextzugriff (PDF)

THU0216 PERIPHERAL PROTEIN BIOMARKER CHANGES FOLLOWING SELECTIVE INHIBITION OF JANUS KINASE 1 (JAK1) BY FILGOTINIB IN METHOTREXATE NAÏVE ADULTS WITH MODERATELY-TO-SEVERELY ACTIVE RHEUMATOID ARTHRITIS (FINCH3)

Annals of the rheumatic diseases, 2020-06, Vol.79 (Suppl 1), p.333-334

2020

Volltextzugriff (PDF)

FRI0136 PERIPHERAL PROTEIN BIOMARKER CHANGES FOLLOWING SELECTIVE INHIBITION OF JANUS KINASE 1 (JAK1) BY FILGOTINIB IN ADULTS WITH MODERATELY-TO-SEVERELY ACTIVE RHEUMATOID ARTHRITIS WITH PRIOR INADEQUATE RESPONSE TO METHOTREXATE (FINCH1)

Annals of the rheumatic diseases, 2020-06, Vol.79 (Suppl 1), p.650-651

2020

Volltextzugriff (PDF)

Exploring paradoxes in the search for sustainable livelihoods: a case study from Tanzania

Environment, development and sustainability, 2018-04, Vol.20 (2), p.527-542

2018

Volltextzugriff (PDF)

SAT0231 Effects of the jak1-selective inhibitor filgotinib on gene expression profile in blood of patients with active rheumatoid arthritis

Annals of the rheumatic diseases, 2018-06, Vol.77 (Suppl 2), p.976

2018

Volltextzugriff (PDF)

Approaches targeting K(V)10.1 open a novel window for cancer diagnosis and therapy

Current medicinal chemistry, 2012, Vol.19 (5), p.675

2012

Volltextzugriff (PDF)

Lip and Perioral Enhancement With Hyaluronic Acid Dermal Fillers in Individuals With Skin of Color

Dermatologic surgery, 2019-07, Vol.45 (7), p.959-967

2019

Volltextzugriff (PDF)

A Multicenter Study of the Safety and Effectiveness of Hyaluronic Acid with a Cohesive Polydensified Matrix for Treatment of Nasolabial Folds in Subjects with Fitzpatrick Skin Types IV, V, and VI

Plastic and reconstructive surgery (1963), 2013-10, Vol.132 (4S-2 Clinical Introduction to the Hyaluronic Acid Dermal Filler Using Cohesive Polydensified Matrix Technology), p.41S-47S

2013

Volltextzugriff (PDF)

Safety and Effectiveness of the Hyaluronic Acid Filler, HYC-24L, for Lip and Perioral Augmentation

Dermatologic surgery, 2015-12, Vol.41 Suppl 1 (Supplement 1), p.S293-S301

2015

Volltextzugriff (PDF)

P8 A retrospective cohort study of idiopathic diaphragmatic palsy: a diagnostic triad, natural history and prognosis

Thorax, 2021-11, Vol.76 (Suppl 2), p.A71-A71

2021

Volltextzugriff (PDF)

POS0446 FILGOTINIB-TREATED RHEUMATOID ARTHRITIS PATIENTS WITH HIGH BASELINE NEUTROPHIL-TO-LYMPHOCYTE RATIO SHOW BETTER CLINICAL RESPONSE RATES AND PATIENT-REPORTED OUTCOMES

Annals of the rheumatic diseases, 2021-06, Vol.80 (Suppl 1), p.452-453

2021

Volltextzugriff (PDF)

Expression of a Polygalacturonase Associated with Tomato Seed Germination

Plant physiology (Bethesda), 1999-10, Vol.121 (2), p.419-428

1999

Volltextzugriff (PDF)

Efficacy, Safety, and Tolerability of Topical Dapsone Gel, 7.5% for Treatment of Acne Vulgaris by Fitzpatrick Skin Phototype

Journal of drugs in dermatology, 2018-02, Vol.17 (2), p.160

2018

Volltextzugriff (PDF)

The Second of Two One-Year, Multicenter, Open-Label, Repeat-Dose, Phase II Safety Studies of PrabotulinumtoxinA for the Treatment of Moderate to Severe Glabellar Lines in Adult Patients

Aesthetic surgery journal, 2021-12, Vol.41 (12), p.1423-1438

2021

Volltextzugriff (PDF)

Granuloma annulare

International journal of dermatology, 1997-05, Vol.36 (5), p.326-333

1997

Volltextzugriff (PDF)

Global Updates on the Future Directions of Neurotoxins and Fillers

Plastic and reconstructive surgery. Global open, 2016-12, Vol.4 (12 Suppl Anatomy and Safety in Cosmetic Medicine: Cosmetic Bootcamp), p.e1177-e1177

2016

Volltextzugriff (PDF)

Rejuvenating Hydrator: Restoring Epidermal Hyaluronic Acid Homeostasis With Instant Benefits

Journal of drugs in dermatology, 2016-01, Vol.15 (1 Suppl 2), p.s24

2016

Volltextzugriff (PDF)

Soluble sugar content of white spruce (Picea glauca) seeds during and after germination

Physiologia plantarum, 2000-09, Vol.110 (1), p.1-12

2000

Volltextzugriff (PDF)

An Open-Label Study Evaluating the Periorbital Skin Rejuvenation Efficacy of a Cosmeceutical Containing Methyl Estradiolpropanoate (MEP) in Women With Estrogen Deficient Skin (EDS)

Journal of drugs in dermatology, 2022-11, Vol.21 (11), p.1185-1190

2022

Volltextzugriff (PDF)

THU0215 WHOLE BLOOD TRANSCRIPTIONAL CHANGES FOLLOWING SELECTIVE INHIBITION OF JANUS KINASE 1 (JAK1) BY FILGOTINIB IN ADULTS WITH MODERATELY-TO-SEVERELY ACTIVE RHEUMATOID ARTHRITIS WITH PRIOR INADEQUATE RESPONSE TO METHOTREXATE (FINCH1)

Annals of the rheumatic diseases, 2020-06, Vol.79 (Suppl 1), p.333-333

2020

Volltextzugriff (PDF)

SAT0155 WHOLE BLOOD TRANSCRIPTIONAL CHANGES FOLLOWING SELECTIVE INHIBITION OF JANUS KINASE 1 (JAK1) BY FILGOTINIB IN MTX-NAÏVE ADULTS WITH MODERATELY-TO-SEVERELY ACTIVE RHEUMATOID ARTHRITIS (RA) (FINCH3)

Annals of the rheumatic diseases, 2020-06, Vol.79 (Suppl 1), p.1017-1018

2020

Volltextzugriff (PDF)

Le filgotinib a démontré une efficacité clinique dans la polyarthrite rhumatoïde indépendamment du statut tabagique : analyse post-hoc en sous-groupes de 3 essais cliniques de phase 3

Revue du rhumatisme (Ed. française : 1993), 2021-12, Vol.88, p.A137-A138

2021

Volltextzugriff (PDF)

Pemphigus vegetans—Neumann variant associated with intranasal heroin abuse

Journal of the American Academy of Dermatology, 1998-11, Vol.39 (5), p.872-875

1998

Volltextzugriff (PDF)

P460 Evaluation of potential mechanisms underlying the safety observations of filgotinib in clinical studies in rheumatoid arthritis

Journal of Crohn's and colitis, 2020-01, Vol.14 (Supplement_1), p.S409-S409

2020

Volltextzugriff (PDF)

1 – 25 von 780

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(666)
Mit Volltextzugriff
(591)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(423)
Life Sciences & Biomedicine
(326)
Humans
(161)
Biological And Medical Sciences
(120)
Male
(85)
Female
(80)
Physical Sciences
(73)
Fundamental And Applied Biological Sciences. Psychology
(68)
Physics
(66)
Medical Sciences
(53)
Animals
(50)
Plant Sciences
(46)
Adult
(45)
Biochemistry & Molecular Biology
(45)
Mutation
(45)
Technology
(39)
Middle Aged
(37)
Microbiology
(36)
Cell Biology
(35)
Aged
(31)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Reply to: Optimising the treatment of HDV infection: efficacy of Bulevirtide, HBV-HDV interactions and the importance of statistical methods

POS0536 FILGOTINIB DEMONSTRATES CLINICAL EFFICACY IN RHEUMATOID ARTHRITIS INDEPENDENT OF SMOKING STATUS: A POST-HOC SUBGROUP ANALYSIS OF THREE PHASE 3 CLINICAL TRIALS

THU0216 PERIPHERAL PROTEIN BIOMARKER CHANGES FOLLOWING SELECTIVE INHIBITION OF JANUS KINASE 1 (JAK1) BY FILGOTINIB IN METHOTREXATE NAÏVE ADULTS WITH MODERATELY-TO-SEVERELY ACTIVE RHEUMATOID ARTHRITIS (FINCH3)

FRI0136 PERIPHERAL PROTEIN BIOMARKER CHANGES FOLLOWING SELECTIVE INHIBITION OF JANUS KINASE 1 (JAK1) BY FILGOTINIB IN ADULTS WITH MODERATELY-TO-SEVERELY ACTIVE RHEUMATOID ARTHRITIS WITH PRIOR INADEQUATE RESPONSE TO METHOTREXATE (FINCH1)

Exploring paradoxes in the search for sustainable livelihoods: a case study from Tanzania

SAT0231 Effects of the jak1-selective inhibitor filgotinib on gene expression profile in blood of patients with active rheumatoid arthritis

Approaches targeting K(V)10.1 open a novel window for cancer diagnosis and therapy

Lip and Perioral Enhancement With Hyaluronic Acid Dermal Fillers in Individuals With Skin of Color

A Multicenter Study of the Safety and Effectiveness of Hyaluronic Acid with a Cohesive Polydensified Matrix for Treatment of Nasolabial Folds in Subjects with Fitzpatrick Skin Types IV, V, and VI

Safety and Effectiveness of the Hyaluronic Acid Filler, HYC-24L, for Lip and Perioral Augmentation

P8 A retrospective cohort study of idiopathic diaphragmatic palsy: a diagnostic triad, natural history and prognosis

POS0446 FILGOTINIB-TREATED RHEUMATOID ARTHRITIS PATIENTS WITH HIGH BASELINE NEUTROPHIL-TO-LYMPHOCYTE RATIO SHOW BETTER CLINICAL RESPONSE RATES AND PATIENT-REPORTED OUTCOMES

Expression of a Polygalacturonase Associated with Tomato Seed Germination

Efficacy, Safety, and Tolerability of Topical Dapsone Gel, 7.5% for Treatment of Acne Vulgaris by Fitzpatrick Skin Phototype

The Second of Two One-Year, Multicenter, Open-Label, Repeat-Dose, Phase II Safety Studies of PrabotulinumtoxinA for the Treatment of Moderate to Severe Glabellar Lines in Adult Patients

Granuloma annulare

Global Updates on the Future Directions of Neurotoxins and Fillers

Rejuvenating Hydrator: Restoring Epidermal Hyaluronic Acid Homeostasis With Instant Benefits

Soluble sugar content of white spruce (Picea glauca) seeds during and after germination

An Open-Label Study Evaluating the Periorbital Skin Rejuvenation Efficacy of a Cosmeceutical Containing Methyl Estradiolpropanoate (MEP) in Women With Estrogen Deficient Skin (EDS)

THU0215 WHOLE BLOOD TRANSCRIPTIONAL CHANGES FOLLOWING SELECTIVE INHIBITION OF JANUS KINASE 1 (JAK1) BY FILGOTINIB IN ADULTS WITH MODERATELY-TO-SEVERELY ACTIVE RHEUMATOID ARTHRITIS WITH PRIOR INADEQUATE RESPONSE TO METHOTREXATE (FINCH1)

SAT0155 WHOLE BLOOD TRANSCRIPTIONAL CHANGES FOLLOWING SELECTIVE INHIBITION OF JANUS KINASE 1 (JAK1) BY FILGOTINIB IN MTX-NAÏVE ADULTS WITH MODERATELY-TO-SEVERELY ACTIVE RHEUMATOID ARTHRITIS (RA) (FINCH3)

Le filgotinib a démontré une efficacité clinique dans la polyarthrite rhumatoïde indépendamment du statut tabagique : analyse post-hoc en sous-groupes de 3 essais cliniques de phase 3

Pemphigus vegetans—Neumann variant associated with intranasal heroin abuse

P460 Evaluation of potential mechanisms underlying the safety observations of filgotinib in clinical studies in rheumatoid arthritis

Suchergebnisse filtern